These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21600312)

  • 21. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis.
    Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence-based treatment of systemic vasculitis.
    Jayne D
    Rheumatology (Oxford); 2000 Jun; 39(6):585-95. PubMed ID: 10888702
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
    Flossmann O; de Groot K
    Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
    [No Abstract]   [Full Text] [Related]  

  • 28. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
    Flossmann O; Jones RB; Jayne DR; Luqmani RA
    Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical feature analysis of 190 patients with anti-neutrophil cytoplasmic antibodies associated vasculitis].
    Chen J; Niu YH; Li GL; Wang GF; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(36):2548-51. PubMed ID: 20137616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Sanders JS; Slot MC; Stegeman CA
    N Engl J Med; 2003 Nov; 349(21):2072-3; author reply 2072-3. PubMed ID: 14627795
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases.
    Geetha D; Seo P; Specks U; Fervenza FC
    Am J Transplant; 2007 Dec; 7(12):2821-5. PubMed ID: 17908274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New insights in the treatment of ANCA-associated systemic vasculitis].
    Sinico RA; Sabadini E
    G Ital Nefrol; 2006; 23(2):138-48. PubMed ID: 16710819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ANCA-associated systemic small-vessel vasculitis.
    Jayne D
    APMIS Suppl; 2009 Jun; (127):3-9. PubMed ID: 19515133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab for rescue and maintenance therapy in rapidly progressive life-threatening antineutrophil cytoplasmic autoantibody-associated systemic vasculitis.
    José RJ; Chrysochou C; Shurrab AE; New D; Wood GN
    Scand J Urol Nephrol; 2010 Dec; 44(6):459-62. PubMed ID: 20645677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
    Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
    Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasculitis of the gallbladder: case report and spectrum of disease.
    Juliano J; Wilson KD; Gertner E
    J Clin Rheumatol; 2009 Mar; 15(2):75-7. PubMed ID: 19265351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.